Patents by Inventor Theodore Friedman

Theodore Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aerosol generation and exposure system
    Patent number: 11000065
    Abstract: A system is disclosed that includes a holder having a pressurized chamber and configured to secure an aerosol delivery device at least partially within the pressurized chamber. A test chamber is connected to the holder, the test chamber having an inlet allowing an aerosol from the aerosol delivery device to enter the test chamber.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: May 11, 2021
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE
    Inventors: Theodore Friedman, Xuesi Max Shao
  • AEROSOL GENERATION AND EXPOSURE SYSTEM
    Publication number: 20190262114
    Abstract: A system is disclosed that includes a holder having a pressurized chamber and configured to secure an aerosol delivery device at least partially within the pressurized chamber. A test chamber is connected to the holder, the test chamber having an inlet allowing an aerosol from the aerosol delivery device to enter the test chamber.
    Type: Application
    Filed: August 2, 2017
    Publication date: August 29, 2019
    Inventors: Theodore FRIEDMAN, Xuesi Max SHAO
  • Lymphokine gene therapy of cancer
    Patent number: 5681562
    Abstract: A novel method of tumor immunotherapy is described comprising the genetic modification of cells resulting in the secretion of cytokine gene products to stimulate a patient's immune response to tumor antigens. In one embodiment, autologous fibroblasts genetically modified to secrete at least one cytokine gene product are utilized to immunize the patient in a formulation with tumor antigens at a site other than an active tumor site. In another embodiment, cells genetically modified to express at least one tumor antigen gene product and to secrete at least one cytokine gene product are utilized in a formulation to immunize the patient at a site other than an active tumor site.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: October 28, 1997
    Assignee: Sidney Kimmel Cancer Center
    Inventors: Robert E. Sobol, Fred H. Gage, Ivor Royston, Theodore Friedman, Habib Fakhrai